Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Dec-18 12:51 PM View:  | Chelius Erik C. Vice President CMC | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 49,895 | $24.00 | $1,197,480.00 | (100%) 49.9K to 0 | < 1% |
| 21-Dec-18 12:53 PM View: | Parker Katherine VP of Human Resources | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 1,200 | $24.00 | $28,800.00 | (100%) 1.2K to 0 | < 1% |
| 21-Dec-18 12:48 PM View: | Graham Dawn Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 7,050 | $24.00 | $169,200.00 | (100%) 7.05K to 0 | < 1% |
| 21-Dec-18 12:47 PM View: | Low Philip S Chief Science Officer Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 132,473 | $24.00 | $3,179,350.00 | (69%) 192.47K to 60.0K | < 1% |
| 21-Dec-18 12:49 PM View: | Taylor Beth VP Finance & Chief Acctg Off | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 1,250 | $24.00 | $30,000.00 | (3%) 40.0K to 38.75K | < 1% |
| 21-Dec-18 12:49 PM View: | Goddard Colin Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 11,100 | $24.00 | $266,400.00 | (100%) 11.1K to 0 | < 1% |
| 21-Dec-18 12:53 PM View: | Armour Alison A. Chief Medical Officer | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 10,500 | $24.00 | $252,000.00 | (13%) 78.0K to 67.5K | < 1% |
| 21-Dec-18 12:46 PM View: | Andriole Michael T. Chief Financial Officer | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 152,582 | $24.00 | $3,661,970.00 | (100%) 152.58K to 0 | < 1% |
| 21-Dec-18 12:47 PM View: | Sherman Michael A. President and CEO Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 243,739 | $24.00 | $5,849,740.00 | (61%) 399.28K to 155.54K | < 1% |
| 21-Dec-18 12:54 PM View: | Middleton Fred A Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 113,489 | $24.00 | $2,723,740.00 | (3%) 4.16M to 4.05M | < 1% |
| 21-Dec-18 12:52 PM View: | Russell Lesley Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 11,100 | $24.00 | $266,400.00 | (100%) 11.1K to 0 | < 1% |
| 21-Dec-18 12:54 PM View: | MacHado Clarence Patrick Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 7,050 | $24.00 | $169,200.00 | (100%) 7.05K to 0 | < 1% |
| 21-Dec-18 12:51 PM View: | Aplin John C Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 32,163 | $24.00 | $771,912.00 | (100%) 32.16K to 0 | < 1% |
| 21-Dec-18 12:53 PM View: | Leamon Christopher P Vice President of Research | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 224,256 | $24.00 | $5,382,140.00 | (100%) 224.26K to 0 | < 1% |
| 21-Dec-18 12:53 PM View: | McAvoy David R. General Counsel | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 25,869 | $24.00 | $620,856.00 | (100%) 25.87K to 0 | < 1% |
| 21-Dec-18 12:47 PM View: | Low Philip S Chief Science Officer Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 60,000 | $24.00 | $1,440,000.00 | (100%) 60.0K to 0 | < 1% |
| 21-Dec-18 12:49 PM View: | Taylor Beth VP Finance & Chief Acctg Off | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 38,750 | $24.00 | $930,000.00 | (100%) 38.75K to 0 | < 1% |
| 21-Dec-18 12:53 PM View: | Armour Alison A. Chief Medical Officer | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 67,500 | $24.00 | $1,620,000.00 | (100%) 67.5K to 0 | < 1% |
| 21-Dec-18 12:47 PM View: | Sherman Michael A. President and CEO Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 19,919 | $24.00 | $478,056.00 | (13%) 155.54K to 135.63K | < 1% |
| 21-Dec-18 12:48 PM View: | Kozin Marc D Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 11,100 | $24.00 | $266,400.00 | (100%) 11.1K to 0 | < 1% |
| 21-Dec-18 12:54 PM View: | Middleton Fred A Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 4,045,620 | $24.00 | $97,094,800.00 | (100%) 4.05M to 0 | < 1% |
| 21-Dec-18 12:53 PM View: | Parker Katherine VP of Human Resources | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 62,797 | $24.00 | $1,507,130.00 | (98%) 64.0K to 1.2K | < 1% |
| 21-Dec-18 12:47 PM View: | Low Philip S Chief Science Officer Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 349,944 | $24.00 | $8,398,660.00 | (65%) 542.42K to 192.47K | < 1% |
| 21-Dec-18 12:49 PM View: | Taylor Beth VP Finance & Chief Acctg Off | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 59,509 | $24.00 | $1,428,220.00 | (60%) 99.51K to 40.0K | < 1% |
| 21-Dec-18 12:53 PM View: | Armour Alison A. Chief Medical Officer | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 72,253 | $24.00 | $1,734,070.00 | (48%) 150.25K to 78.0K | < 1% |
| 21-Dec-18 12:47 PM View: | Sherman Michael A. President and CEO Director | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 135,626 | $24.00 | $3,255,020.00 | (100%) 135.63K to 0 | < 1% |
| 21-Dec-18 12:53 PM View: | Armour Alison A. Chief Medical Officer | Endocyte, Inc. (ECYT) | 20-Dec-18 | Gift | 10,500 | -- | -- | 7% 150.25K to 160.75K | |
| 21-Dec-18 12:53 PM View: | Armour Alison A. Chief Medical Officer | Endocyte, Inc. (ECYT) | 20-Dec-18 | Gift | 10,500 | -- | -- | (7%) 160.75K to 150.25K | |
| 19-Dec-18 4:30 PM View: | Taylor Beth VP Finance & Chief Acctg Offcr | Endocyte, Inc. (ECYT) | 19-Dec-18 | Gift | 3,186 | -- | -- | (3%) 102.69K to 99.51K | |
| 21-Dec-18 12:53 PM View: | Parker Katherine VP of Human Resources | Endocyte, Inc. (ECYT) | 18-Dec-18 | Gift | 8,229 | -- | -- | (11%) 72.23K to 64.0K | |
| 19-Dec-18 4:13 PM View: | Sherman Michael A. President and CEO Director | Endocyte, Inc. (ECYT) | 17-Dec-18 | Option Exercise | 115,559 | $6.52 | $753,784.00 | 31% 367.84K to 483.4K | |
| 19-Dec-18 4:30 PM View: | Taylor Beth VP Finance & Chief Acctg Offcr | Endocyte, Inc. (ECYT) | 17-Dec-18 | Gift | 3,750 | -- | -- | (4%) 106.44K to 102.69K | |
| 19-Dec-18 4:13 PM View: | Low Philip S Chief Science Officer Director | Endocyte, Inc. (ECYT) | 17-Dec-18 | Option Exercise | 140,214 | $5.52 | $774,202.00 | 35% 402.2K to 542.42K | |
| 19-Dec-18 4:13 PM View: | Sherman Michael A. President and CEO Director | Endocyte, Inc. (ECYT) | 17-Dec-18 | Gift | 84,112 | -- | -- | (17%) 483.4K to 399.28K | |
| 19-Dec-18 4:14 PM View: | Andriole Michael T. Chief Financial Officer | Endocyte, Inc. (ECYT) | 17-Dec-18 | Gift | 4,500 | -- | -- | (3%) 157.08K to 152.58K | |
| 19-Dec-18 4:30 PM View: | Taylor Beth VP Finance & Chief Acctg Offcr | Endocyte, Inc. (ECYT) | 17-Dec-18 | Gift | 1,250 | -- | -- | 2% 56.34K to 57.59K | |
| 19-Dec-18 4:30 PM View: | Taylor Beth VP Finance & Chief Acctg Offcr | Endocyte, Inc. (ECYT) | 17-Dec-18 | Option Exercise | 48,854 | $4.31 | $210,509.00 | 85% 57.59K to 106.44K | |
| 19-Dec-18 4:13 PM View: | Armour Alison A. Chief Medical Officer | Endocyte, Inc. (ECYT) | 17-Dec-18 | Option Exercise | 49,213 | $4.59 | $225,796.00 | 49% 101.04K to 150.25K | (2%) |
| 19-Dec-18 4:14 PM View: | Andriole Michael T. Chief Financial Officer | Endocyte, Inc. (ECYT) | 17-Dec-18 | Option Exercise | 25,000 | $2.22 | $55,500.00 | 19% 132.08K to 157.08K | |
| 19-Dec-18 4:14 PM View: | Leamon Christopher P Vice President of Research | Endocyte, Inc. (ECYT) | 17-Dec-18 | Option Exercise | 101,774 | $5.14 | $523,488.00 | 83% 122.48K to 224.26K | |
| 19-Dec-18 4:13 PM View: | Low Philip S Chief Science Officer Director | Endocyte, Inc. (ECYT) | 12-Dec-18 | Gift | 52,512 | -- | -- | (10%) 506.54K to 454.02K | |
| 19-Dec-18 4:13 PM View: | Low Philip S Chief Science Officer Director | Endocyte, Inc. (ECYT) | 12-Dec-18 | Gift | 52,346 | -- | -- | (12%) 454.02K to 401.68K | |
| 21-Dec-18 12:54 PM View: | Middleton Fred A Director | Endocyte, Inc. (ECYT) | 11-Dec-18 | Gift | 83,860 | -- | -- | (2%) 4.24M to 4.16M | |
| 09-Oct-18 2:16 PM View: | Andriole Michael T. Chief Financial Officer | Endocyte, Inc. (ECYT) | 09-Oct-18 | Market Sale (Planned) | 635 | $15.85 | $10,064.80 | (< 1%) 132.72K to 132.08K | (51%) |
| 09-Oct-18 2:16 PM View: | Andriole Michael T. Chief Financial Officer | Endocyte, Inc. (ECYT) | 05-Oct-18 | Market Sale (Planned) | 17,283 | $15.55 | $268,784.00 | (12%) 150.0K to 132.72K | (54%) |
| 09-Oct-18 2:18 PM View: | Sherman Michael A. President and CEO Director | Endocyte, Inc. (ECYT) | 05-Oct-18 | Market Sale (Planned) | 28,146 | $15.55 | $437,752.00 | (7%) 395.98K to 367.84K | (54%) |
| 09-Oct-18 2:20 PM View: | Leamon Christopher P Vice President of Research | Endocyte, Inc. (ECYT) | 05-Oct-18 | Market Sale (Planned) | 9,028 | $15.56 | $140,437.00 | (7%) 130.38K to 121.35K | (54%) |
| 09-Oct-18 2:16 PM View: | Chelius Erik C. Vice President CMC | Endocyte, Inc. (ECYT) | 05-Oct-18 | Market Sale (Planned) | 4,514 | $15.56 | $70,242.80 | (8%) 54.41K to 49.9K | (54%) |
| 09-Oct-18 2:21 PM View: | Armour Alison A. Chief Medical Officer | Endocyte, Inc. (ECYT) | 05-Oct-18 | Market Sale (Planned) | 9,111 | $15.56 | $141,748.00 | (8%) 110.15K to 101.04K | (54%) |
| 09-Oct-18 2:14 PM View: | Parker Katherine VP of Human Resources | Endocyte, Inc. (ECYT) | 05-Oct-18 | Market Sale (Planned) | 6,771 | $15.55 | $105,316.00 | (9%) 78.32K to 71.55K | (54%) |
